Penicillin- and cephalosporin-resistant Streptococcus pneumoniae

Drugs

Volumn 58, Issue 1, 1999, Pages 1-4

  Klugman, Keith P ^a,c   Feldman, Charles ^b  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; DEXAMETHASONE; MEROPENEM; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TROVAFLOXACIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PHARMACODYNAMICS; PNEUMONIA; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

CEPHALOSPORIN RESISTANCE; HUMANS; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0032806887     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199958010-00001     Document Type: Article

References (29)

1. 1. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3: 171-96
2. 2. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77-83
3. 3. Sacho H, Klugman KP, Koornhof KP, et al. Community-acquired pneumonia in an adult due to a multiply-resistant pneumococcus [letter]. J Infect 1987; 14: 188-9
4. 4. Feldman C, Kallenbach JM, Miller SD, et al. Community-acquired pneumonia due to penicillin-resistant pneumococci. N Engl J Med 1985; 313: 615-7
5. 5. Pallares R, Gudiol F, Linares J, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987; 317: 18-22
6. 6. Austrian R, Gold J. Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964; 60: 759-76
7. 7. Klugman KP. Management of antibiotic-resistant pneumococcal infections. J Antimicrob Chemother 1994; 34: 191-3
8. 8. Feldman C, Klugman K. Antibiotic-resistant pneumococcal pneumonia. S Afr Med J 1996; 86: 28-30
9. 9. Friedland IR, Klugman KP. Failure of chloramphenicol in penicillin-resistant pneumococcal meningitis. Lancet 1992; 339: 405-8
10. 10. Bradley JS, Connor JD. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr Infect Dis J 1991; 10: 871-3
11. 11. Friedland IR, McCracken Jr GH. Management of infections by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994; 331: 377-82
12. 12. Klugman KP, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 1995; 39: 1988-92
13. 13. Friedland IR, Klugman KP. Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high dosage cefotaxime. Antimicrob Agents Chemother; 41: 1888-91
14. 14. Klugman KP, Dagan R, Meropenem Meningitis Study Group. A randomized comparison of meropenem with cefotaxime for the treatment of bacterial meningitis. Antimicrob Agents Chemother 1995; 39: 1140-6
15. 15. Friedland IR, Klugman KP. Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child 1992; 146: 920-3
16. 16. Choi E-H, Lee H-J. Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children. Clin Infect Dis 1998; 26: 1346-54
17. 17. Deeks SL, Palacio R, Ruvinsky R, et al. Risk factors und course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group. J Pediatr 1999 Feb; 103 (2): 409-13
18. 18. Silverstein M, Chumpa A, Bachur R, et al. Clinical implications of penicillin and ceftriaxone resistance among children with pneumococcal bacteremia [abstract K-90]. Toronto, Canada: ICAAC, 1997; P343
19. 19. Buckingham SC, Brown SP, San Joaquin VH. Break-through bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia. J Pediatr 1998; 132: 174-6
20. 20. Pallares T, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333: 474-80
21. 21. Destache CJ, Pakiz CB, McConnell S et al. Effect of penicillin (PCN) susceptibility on hospitalization length and mortality in Streptococcus pneumoniae infections [abstract K-89]. 37th International Conference on Antimicrobial Agents and Chemotherapy 1997 Sep 28-Oct 1; Toronto, P343
22. 22. Plouffe JF, Breiman RF, Facklam RR. Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention. JAMA 1996; 275: 194-8
23. 23. Mularczyk M, Leophonte P, Rouquet RM, et al. Resistant and susceptible penicillin pneumococcal pneumonia-comparative study [abstract K-88]. 37th International Conference on Antimicrobial Agents and Chemotherapy 1997 Sep 28-Oct 1; Toronto, P343
24. 24. Scaglione F, Raichi M, Fraschini F. Serum protein binding and extravascular diffusion of methoxyimino cephalosporins: time courses of free and total concentrations of cefotaxime and ceftriaxone in serum and pleural exudate. J Antimicrob Chemother 1990; 26 (A Suppl.); 1-10
25. 25. Craig WA, Andes D. Pharmacokinetic and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996; 15: 255-9
26. 26. Dagan R, Abramson O, Leibovitz E, et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr Infect Dis J 1996; 15: 980-5
27. 27. Dagan R, Liebovitz E, Greenberg D, et al. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. Pediatr Infect Dis J 1998; 17: 776-82
28. 28. Dowell S, Butler J, Giebink S, et al. Acute otitis media: management and surveillance in the era of pneumococcal resistance: a report from the Drug-resistant streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999 Jan; 18: 1-9
29. 29. Kaplan SL, Mason EO. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev 1998; 11: 628-44